Stock Evaluator: Bayer Aktiengesellschaft (BAYRY)

Bayer Aktiengesellschaft BAYRY

$13.84 -0.13 -0.93%
July 31, 2026 12:59:23 PM EST November 10, 2021 Volume: 222,264
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Pharmaceuticals

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Commentary & Analysis


Financial Summary

Share Statistics BAYRY Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $54,492.9 $569.9 94%
Shares Out (Mil) 1,132.7 44.8 95%
Institutional Ownership 50.0% 84.6% 30%
Float (Mil) 982.4 45.1 91%
Beta 0.84 0.67 50%
Avg Daily Volume (000s) 762 294 66%
Price Change
(52-week)
70.4% 65.2% 87%
Growth BAYRY Industry
Median
Percentile
(All Stocks)
Sales (5yr) 1.1% 6.7% 20%
Net Income (5yr) 19.8% (2.0%) 73%
EPS (5yr) 19.8% 14.9% 67
Dividends (5yr) (44.5%) 0.0% 58%
Cash Flow (5yr) (13.8%) (14.9%) 56%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 1 2 2
Current EPS $0.255 $1.158 $1.239
Month Ago EPS $0.898 $5.086 $5.384
# Rev Up 1 0 0
# Rev Down 0 1 0
Three Months Ago EPS $1.027 $4.899 $5.459
Year/Year Chg na (126.8%) (132.5%)
Financials BAYRY Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $52,164 $230 97%
Net Income (TTM) (Mil) ($2,486) ($11) 0%
EPS (TTM) ($2.530) ($0.600) 12%
Operating Cash Flow (TTM) (Mil) $5,939 ($6) 96%
Net Cash Flow (TTM) (Mil) $2,051 $4 97%
Long-Term Debt (Q1) (Mil) $35,379 $7 97%
Enterprise Value (Q1) (Mil) $80,303 $493 95%
Valuation BAYRY Industry
Median
Percentile
(All Stocks)
P/B na 2.89 na
P/E na 20.6 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 1.1 na
Ratios BAYRY Industry
Median
Percentile
(All Stocks)
Gross Margin 59.9% 65.9% 73%
Net Margin (4.8%) (0.2%) 25%
ROA (2.1%) (25.5%) 34%
ROE (7.3%) (21.4%) 29%
Liabilities to Assets 73.2% 35.5% 68%
F-Score na 3 na

Bayer Aktiengesellschaft did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors